• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Treatment of In-stent Restenosis of the Internal Carotid Artery Using Drug-eluting Balloons
ConclusionThe use of DEB angioplasty is a  safe and effective treatment of ICA ISR lesions, yielding significantly better results compared to other modalities. Randomized multicenter studies are warranted.
Source: Clinical Neuroradiology - September 7, 2023 Category: Neurology Source Type: research

First clinical experience with the Derivo 2heal embolization device for the treatment of intracranial aneurysms
CONCLUSIONS: The preliminary results of the new Derivo® 2heal® Embolization Device appear promising and warrant further evaluation by multicentre studies with long-term follow-up.PMID:37574801 | DOI:10.1177/15910199231193577
Source: Interventional Neuroradiology - August 14, 2023 Category: Radiology Authors: Lukas Goertz David Zopfs Michael Sch önfeld Charlotte Zaeske Lenhard Pennig Gerrit Brinker Marc Schlamann Christoph Kabbasch Source Type: research

Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology
Circulation. 2022 Apr 19;145(16):1254-1284. doi: 10.1161/CIRCULATIONAHA.121.058229. Epub 2022 Apr 18.ABSTRACTThe Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular microaxial flow pump that is currently used for (1) cardiogenic shock, (2) left ventricular unloading (combination of venoarterial extracorporeal membrane oxygenation and Impella concept), (3) high-risk percutaneous coronary interventions, (4) ablation of ventricular tachycardia, and (5) treatment of right ventricular failure. Impella-assisted forward blood flow increased mean arterial pressure and cardiac output, peripheral tissue pe...
Source: Circulation - April 18, 2022 Category: Cardiology Authors: Enzo L üsebrink Antonia Kellnar Kathrin Krieg Leonhard Binzenh öfer Clemens Scherer Sebastian Zimmer Benedikt Schrage Stephanie Fichtner Tobias Petzold Daniel Braun Sven Peterss Stefan Brunner Christian Hagl Dirk Westermann J örg Hausleiter Steffen Mas Source Type: research

PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function
Conclusions: Our findings reveal no relation of PCSK9 with baseline eGFR and albuminuria, but a significant association between higher PCSK9 concentrations and risk of cardiovascular disease independent of traditional risk factors including LDL-cholesterol levels.PMID:35387881 | DOI:10.2215/CJN.01230122
Source: Clinical Journal of the American Society of Nephrology : CJASN - April 7, 2022 Category: Urology & Nephrology Authors: Azin Kheirkhah Claudia Lamina Barbara Kollerits Johanna Schachtl-Riess Ulla Schultheiss Lukas Forer Peggy Sekula Fruzsina Kotsis Kai-Uwe Eckardt Florian Kronenberg Source Type: research

Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany
CONCLUSION: The preferred therapy after PCI in patients with AF is DAT with a NOAC and clopidogrel. In-hospital ischemic and bleeding events were rare. The recommended durations for combination therapy vary considerably.PMID:35243515 | DOI:10.1007/s00059-022-05099-6
Source: Herz - March 4, 2022 Category: Cardiology Authors: Uwe Zeymer Ralph Toelg Harm Wienbergen Hans-Peter Hobbach Alessandro Cuneo Raffi Bekeredjian Oliver Ritter Birgit Hailer Klaus Hertting Marcus Hennersdorf Werner Scholtz Peter Lanzer Harald Mudra Markus Schwefer Peter-Lothar Schwimmbeck Christoph Liebetra Source Type: research

Leave Nothing Behind: Treatment of Intracranial Atherosclerotic Disease with Drug-Coated Balloon Angioplasty
ConclusionIn this study, the application of DCBs to treat ICAD patients was feasible and safe. A  larger scale clinical trial is warranted to further evaluate the safety and efficacy of this treatment.
Source: Klinische Neuroradiologie - July 26, 2020 Category: Radiology Source Type: research

Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry
Conclusions: Patients undergoing protected high-risk percutaneous coronary intervention with Impella support showed an acceptable 180-day clinical outcome regarding major adverse cardiac event and mortality.
Source: Coronary Artery Disease - April 9, 2020 Category: Cardiology Tags: PCI Source Type: research

Pages: 1  2